(Updated - June 3, 2024 7:13 AM EDT)

Oppenheimer analyst Leland Gershell lowered the price target on Immunovant (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE